525
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Possible preventive effect of salazosulfapyridine against development of Pneumocystis pneumonia in methotrexate-receiving patients with rheumatoid arthritis

, , , , , , , , , , & show all
Pages 976-978 | Received 03 Aug 2015, Accepted 05 Nov 2015, Published online: 23 Dec 2015
 

Conflict of interest

H. Kameda has received research grants from AbbVie GK, Astellas Pharma, Chugai Pharmaceutical Co, Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co. Ltd., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd.; speaking fees from AbbVie GK, Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co. Ltd., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB Pharma; consultant fees from Eli Lilly Japan K.K., Novartis Pharma K.K. and Sanofi K.K.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.